Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials in progress
378 A first in-human, multicenter, open-label, dose-finding phase 1 study of the immune stimulator antibody conjugate NJH395 in patients with nonbreast HER2+ advanced malignancies
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 378 A first in-human, multicenter, open-label, dose-finding phase 1 study of the immune stimulator antibody conjugate NJH395 in patients with nonbreast HER2+ advanced malignancies